# OnCo record nct00083382 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00083382/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00083382", "NCT00083382" ;
  schema:name "Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide"@en ;
  schema:description "A phase 2 trial of Pamidronate, Thalidomide and Zoledronic acid in Multiple myeloma, run by University of Arkansas, completed."@en ;
  schema:url <https://onco.cc/trials/nct00083382/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00083382> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/pamidronate/>, <https://onco.cc/drugs/thalidomide/>, <https://onco.cc/drugs/zoledronic-acid/> .